• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Anavex Life Sciences Corp's Alzheimer's drug application rejected by the EU
21:05
Nov25
Annavik Life Sciences Reports No Revenue in FY2025, Cash and Operating Funds Decline
21:33
Anavex Life Science released FY2025 Q4 earnings during market hours on November 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1144 (forecast USD -0.15)
21:00
Anavex Life Science released FY2025 Annual Earnings on November 25 During-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5437 (forecast USD -0.5766)
21:00
Nov19
Anavex Life Sciences Corp. is a biopharmaceutical company focused on developing innovative treatments for multiple diseases
13:33
Nov18
Anavex Life Science to Release FY2025 Q4 Earnings on November 25 During-Market EST, Forecast Revenue USD 0, EPS USD -0.15
00:06

Schedules & Filings

Schedules
Filings
Nov25
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -9.827 M, EPS -0.1144

Aug12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -13.24 M, EPS -0.1551

May13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -11.2 M, EPS -0.1316

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More